Common Contracts

CERTAIN INFORMATION IDENTIFIED BY BRACKETED ASTERISKS ([* * *]) HAS BEEN OMITTED FROM THIS EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.

Patent Cross-License Agreement • August 6th, 2020 • Dicerna Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts

• Contract Type
  Patent Cross-License Agreement
• Filed
  August 6th, 2020
• Company
  Dicerna Pharmaceuticals Inc
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Massachusetts

PATENT CROSS-LICENSE AGREEMENT between DICERNA PHARMACEUTICALS, INC. and ALNYLAM PHARMACEUTICALS, INC. April 3, 2020

Patent Cross-License Agreement • August 6th, 2020 • Alnylam Pharmaceuticals, Inc. • Pharmaceutical preparations • Massachusetts

• Contract Type
  Patent Cross-License Agreement
• Filed
  August 6th, 2020
• Company
  Alnylam Pharmaceuticals, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Massachusetts

THIS PATENT CROSS-LICENSE AGREEMENT (the “Agreement”), effective as of April 3, 2020 (the “Effective Date”), is by and between Dicerna Pharmaceuticals, Inc., a corporation organized and existing under the laws of Delaware, with its principal business office located at 33 Hayden Avenue, Lexington, MA 02421 (“Dicerna”) and Alnylam Pharmaceuticals, Inc., a corporation organized and existing under the laws of Delaware, with its principal business office located at 675 West Kendall Street, Henri A. Termeer Square, Cambridge, MA 02142 (“Alnylam”). Dicerna and Alnylam are each referred to individually as a “Party” and together as the “Parties”.